Clinical trial
A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis
NCT00094887 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Nitric Oxide for Inhalation in the Acute Treatment of Sickle Cell Pain Crisis
- Lead sponsor
- Mallinckrodt
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- December 31, 2008
- Enrollment
- 150 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.